Hope Sellars
Adult Health · Maryville, TNNPI 1619254968
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,803 of the $6,579 with a category attached, or 88.2%. It is spread thinly across 34 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$962
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$796
- Novartis$629
- Impulse Dynamics (USA) Inc.$529
- Johnson & Johnson$506
- Medtronic$351
- plus $3K from 28 others
What the payments were for
- Travel & lodging$72711%
- Food & beverage$5,80388%
- Education$481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 50 | $962 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 39 | $796 |
| Novartis | 50 | $629 |
| Impulse Dynamics (USA) Inc. | 2 | $529 |
| Johnson & Johnson | 25 | $506 |
| Medtronic | 11 | $351 |
| Boston Scientific | 6 | $278 |
| Pfizer | 21 | $274 |
| Novo Nordisk | 4 | $203 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $198 |
| Edwards Lifesciences | 8 | $157 |
| Abbott | 3 | $154 |
| Kiniksa Pharmaceuticals International, PLC | 7 | $152 |
| Cvrx, Inc. | 2 | $146 |
| E.r. Squibb & Sons, L.L.C. | 7 | $140 |
| Atricure, Inc. | 8 | $137 |
| Daiichi Sankyo Inc. | 5 | $132 |
| Heartflow, Inc. | 4 | $123 |
| Sanofi-aventis U.S. LLC | 6 | $102 |
| Inspire Medical Systems, Inc. | 2 | $83 |
| Actelion Pharmaceuticals US, Inc. | 4 | $79 |
| Scpharmaceuticals Inc. | 3 | $58 |
| Alnylam Pharmaceuticals Inc. | 3 | $57 |
| Abiomed | 1 | $56 |
| Sanofi | 2 | $50 |
| Boehringer Ingelheim | 2 | $48 |
| AstraZeneca | 3 | $36 |
| Philips North America LLC | 2 | $31 |
| Baxter Healthcare | 1 | $21 |
| Vital Connect, Inc | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Inogen, Inc. | 1 | $17 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMIZER$990
- XARELTO$164
- ARCALYST$122
- Repatha$121
- Barostim Neo System$119
- MitraClip System$118
- Farapulse$110
How this compares
$6,579 in reported general payments places this provider in the 90th percentile of 352 adult health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 375 | $402,870 |
| XareltoRivaroxaban | 113 | $121,187 |
| Repatha SureclickEvolocumab | 80 | $64,928 |
| EntrestoSacubitril/Valsartan | 26 | $35,331 |
| JardianceEmpagliflozin | 16 | $17,436 |
| MultaqDronedarone Hcl | 11 | $12,349 |
| Dofetilide | 56 | $9,310 |
| Praluent PenAlirocumab | 14 | $6,646 |
| Amiodarone Hcl | 107 | $4,325 |
| Flecainide Acetate | 101 | $3,030 |
| Metoprolol Succinate | 196 | $2,653 |
| Ranolazine ErRanolazine | 15 | $1,932 |
| Midodrine Hcl | 13 | $1,798 |
| Atorvastatin Calcium | 177 | $1,587 |
| Diltiazem 24hr ErDiltiazem Hcl | 36 | $1,306 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $274 | $402,870375 claims |
| Johnson & JohnsonXarelto | $506 | $121,187113 claims |
| NovartisEntresto | $629 | $35,33126 claims |
| Boehringer IngelheimJardiance | $48 | $17,43616 claims |
| Sanofi-aventis U.S. LLCMultaq | $102 | $12,34911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 352 adult health providers in Tennessee.
Other adult health in Maryville
- Brenda BaxterNashville$246K
- Artangela HenryMemphis$74K
- Luisa LealNashville$49K
- Robbie LeinartKnoxville$48K
- Terrye MastinMemphis$34K
- Marshe TurnerMemphis$21K
- Sonya KnightSevierville$17K
- Emily LeidigBristol$17K
- Tamera PaceNashville$16K
- Jocelyn McGuireClarksville$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.